港股異動 | 中國飛鶴(6186.HK)漲逾4% 多家機構唱多
格隆匯9月15日丨中國飛鶴(6186.HK)漲逾4%,報18港元,總市值1608億港元。花旗發表研究報告稱,中國飛鶴擬以每股0.63港元收購原生態牧業,將可使飛鶴能夠提前獲得優質的國內鮮奶資源,並將鮮奶供應短缺的潛在風險降至最低,維持其“買入”評級,目標價22.1港元。浙商證券亦發佈最新研報稱,飛鶴過去集中在低線城市深耕,未來將在高端化趨勢下發力一二線市場,在擁有執行力強的團隊、“更適合中國寶寶體質”的產品、成熟的渠道、持續升級的品牌力後,有望在一二線城市快速崛起,公司市佔率存在至少翻倍的空間。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.